Literature DB >> 1694176

A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein".

H L Jackman1, F L Tan, H Tamei, C Beurling-Harbury, X Y Li, R A Skidgel, E G Erdös.   

Abstract

We discovered an enzyme in human platelets that deamidates substance P and other tachykinins. Because an amidated carboxyl terminus is important for biological activity, we purified and characterized this deamidase. The enzyme, released from human platelets by thrombin, was purified to homogeneity by ammonium sulfate precipitation, followed by chromatography on an octyl-Sepharose column and chromatofocusing on PBE 94. The purified enzyme exhibits esterase, peptidase, and deamidase activities. The peptidase activity (with furylacryloyl-Phe-Phe) is optimal at pH 5.0 while the esterase (benzoyl-tyrosine ethyl ester) and deamidase (D-Ala2-Leu5-enkephalinamide) activities are optimal at pH 7.0. With biologically important peptides, the enzyme acts both as a deamidase (substance P, neurokinin A, and eledoisin) and a carboxy-peptidase (with bradykinin, angiotensin I, substance P-free acid, oxytocin-free acid) at neutrality, although the carboxypeptidase action is faster at pH 5.5. Enkephalins, released upon deamidation of enkephalinamides, were not cleaved. Gly9-NH2 of oxytocin was released without deamidation. Peptides with a penultimate Arg residue were not hydrolyzed. Some properties of the deamidase are similar to those reported for cathepsin A. The deamidase is inhibited by diisopropylfluorophosphate, inhibitors of chymotrypsin-type enzymes, and mercury compounds while other inhibitors of catheptic enzymes, trypsin-like enzymes, and metalloproteases were ineffective. In gel filtration, the native enzyme has an Mr = 94,000 while in non-reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis the Mr = 52,000 indicating it exists as a dimer. After reduction, deamidase dissociates into two chains of Mr = 33,000 and 21,000 as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. [3H]diisopropylfluorophosphate labeled the active site serine in the Mr = 33,000 chain. The first 25 amino acids of both chains were sequenced. They are identical with the sequences of the two chains of lysosomal "protective protein" which, in turn, has sequence similarity to the KEX1 gene product and carboxypeptidase Y of yeast. This protective protein complexes with beta-galactosidase and neuraminidase in lysosomes and is vitally important in maintaining their activity and stability. A defect in this protein is the cause of galactosialidosis, a severe genetic disorder. The ability of physiological stimuli (e.g. thrombin or collagen) to release the deamidase from platelets indicates that it may also be involved in the local metabolism of bioactive peptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694176

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

Review 2.  Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.

Authors:  Ervin G Erdös; Fulong Tan; Randal A Skidgel
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

3.  Clinical utility of whole-exome sequencing in rare diseases: Galactosialidosis.

Authors:  Carlos E Prada; Claudia Gonzaga-Jauregui; Rebecca Tannenbaum; Samantha Penney; James R Lupski; Robert J Hopkin; V Reid Sutton
Journal:  Eur J Med Genet       Date:  2014-04-24       Impact factor: 2.708

Review 4.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

Review 5.  Lysosomal multienzyme complex: pros and cons of working together.

Authors:  Erik J Bonten; Ida Annunziata; Alessandra d'Azzo
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

6.  Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131.

Authors:  Gabriel Birkus; Ruth Wang; Xiaohong Liu; Nilima Kutty; Holly MacArthur; Tomas Cihlar; Craig Gibbs; Swami Swaminathan; William Lee; Martin McDermott
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

7.  Stable expression of protective protein/cathepsin A-green fluorescent protein fusion genes in a fibroblastic cell line from a galactosialidosis patient. Model system for revealing the intracellular transport of normal and mutated lysosomal enzymes.

Authors:  Y Naganawa; K Itoh; M Shimmoto; S Kamei; K Takiguchi; H Doi; H Sakuraba
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

8.  Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.

Authors:  Zhenlong Chen; Fulong Tan; Ervin G Erdös; Peter A Deddish
Journal:  Hypertension       Date:  2005-10-24       Impact factor: 10.190

9.  Prolylcarboxypeptidase regulates food intake by inactivating alpha-MSH in rodents.

Authors:  Nicholas Wallingford; Bertrand Perroud; Qian Gao; Anna Coppola; Erika Gyengesi; Zhong-Wu Liu; Xiao-Bing Gao; Adam Diament; Kari A Haus; Zia Shariat-Madar; Fakhri Mahdi; Sharon L Wardlaw; Alvin H Schmaier; Craig H Warden; Sabrina Diano
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

10.  Naturally occurring active N-domain of human angiotensin I-converting enzyme.

Authors:  P A Deddish; J Wang; B Michel; P W Morris; N O Davidson; R A Skidgel; E G Erdös
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.